CellFE, a company that is developing a microfluidics-based device for delivering gene-editing molecules, announced it raised $4.8 million in Series Seed funding.
Johnson & Johnson is ramping up its capacity for producing 1 billion doses of an experimental lead vaccine candidate for SARS-CoV-2 -- known as coronavirus.
Facebook is committing $100 million in grant money and promised ad spending for helping news outlets dealing with financial struggles due to the COVID-19 outbreak.
Gilead is expanding on its access to the experimental anti-coronavirus drug remdesivir in order to accelerate the emergency use for multiple severely ill patients.
Startup accelerator program Y Combinator is now fast-tracking funding for companies that are focused on combating the coronavirus pandemic.
Pulse 2.0 NewsletterDaily business and finance intelligence.
Subscribe to the Pulse 2.0 Newsletter
Stay informed with the day's intelligence on business, finance, capital markets, deal flow, law, tech, and AI delivered to your inbox each evening at 6pm ET.